Introduction
Necrotising soft tissue infection (NSTI) is a rapidly progressing disease that presents a surgical emergency. Timely antibiotics, radical debridement of infected tissues and adjuvant hyperbaric oxygen therapy are the foundations of its treatment. With improved recognition and management of NSTI in recent years, mortality rates have declined but patients are often left with large, morbid soft tissue defects. 1 Split-skin graft (SSG) is the main reconstruction technique due to its simplicity and dependability. To graft a wound bed requires a blood supply, minimal bioburden and sufficient drainage of potential collections. 1 However, where there is a contaminated wound with extensive soft tissue loss and exposed tendons, SSGs are at risk of failure. Further, SSGs do not properly replace the lost dermis and are prone to rigidly adhere to underlying structures. 2, 3 Dermal substitutes, as well as creating a suitable wound bed for grafting, aim to recreate the inherent thickness and pliability of skin. 4 (Figure 1 ) was 32% of body surface area. Twenty-four days after implantation the BTM's surface sealing layer was 'delaminated', revealing a vascularised matrix. The right leg anterior compartment tendons were no longer exposed.
The wounds were then reconstructed using a 2:1 meshed SSG.
final SSG he has achieved 10° of dorsiflexion and 30° of plantarflexion in his right ankle. He is currently walking independently without aids, working fulltime in sales and has returned to surfing. Exposed tendons in the presence of infection and where there is large TBSA soft tissue loss pose a reconstructive dilemma. 1, 6, 7 When faced with the problem of preserving exposed tendons in a wound where skin grafting alone will not suffice, there is a lack of local tissue transfer options and any free tissue transfer is both technically challenging and at risk of failure. [7] [8] [9] Contributing to this difficulty shark cartilage glycosaminoglycan and sealed with a non-porous silicone layer. 4, 5 Integra succeeds in forming a neo-dermis while biodegrading and its use in NSTI has been advocated. 6, 7 Nevertheless, its high cost, vulnerability to infection and induced host response that leads to extrusion are all causes for concern. 4, 5 NovoSorb™ BTM is a biodegradable polyurethane foam sealed with a removable non-biodegradable polyurethane outer layer. [2] [3] [4] [5] 10 As it is a synthetic dermal template it avoids the risk of immunogenic rejection and the potential disease transmission involved in animal-or human-based products. [2] [3] [4] [5] In preliminary studies on animals and humans, BTM supported the ingrowth of host fibroblasts,
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deposition of dermal collagen matrix and neovascularisation. [2] [3] [4] [5] 10 It also allowed the migration of keratinocytes from the wound edge and basement membrane formation. 
